Different and Divergent Regulation of the KIR2DL4 and KIR3DL1 Promoters1

The killer Ig-like receptors (KIR) are a family of highly related MHC class I receptors that show extreme genetic polymorphism both within the human population and between closely related primate species, suggestive of rapid evolutionary diversification. Most KIR are expressed in a variegated fashion by the NK population, giving rise to an NK repertoire of specificities for MHC class I. We compared the promoter for KIR3DL1, which exhibits variegated gene expression, with that for KIR2DL4, which is expressed by all NK cell clones. Maximum transcriptional activity of each was encoded within ∼270 bp upstream of the translation initiation codon. The KIR2DL4 promoter drove reporter gene expression only in NK cells, while the KIR3DL1 promoter was active in a range of cell types, suggesting that the latter requires other regulatory elements for physiological expression. In NK cells, reporter gene expression driven by the KIR2DL4 promoter was greater than that driven by the KIR3DL1 promoter. DNase I footprinting revealed that transcription factor binding sites differ between the two promoters. The data indicate that while the promoters of these two KIR genes share 67% nucleotide identity, they have evolved distinct properties consistent with different roles in regulating the generation of NK repertoire.

[1]  Michael J. Wilson,et al.  DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells , 2003, The Journal of experimental medicine.

[2]  H. Trompeter,et al.  Crucial Role of DNA Methylation in Determination of Clonally Distributed Killer Cell Ig-like Receptor Expression Patterns in NK Cells1 , 2002, The Journal of Immunology.

[3]  E. Adams,et al.  NK Cell Receptors of the Orangutan (Pongo pygmaeus): A Pivotal Species for Tracking the Coevolution of Killer Cell Ig-Like Receptors with MHC-C1 , 2002, The Journal of Immunology.

[4]  Z. Husain,et al.  Complex expression of natural killer receptor genes in single natural killer cells , 2002, Immunology.

[5]  W. O'Fallon,et al.  Formation of the Killer Ig-Like Receptor Repertoire on CD4+CD28null T Cells1 , 2002, The Journal of Immunology.

[6]  M. Uhrberg,et al.  KIR expression shapes cytotoxic repertoires: a developmental program of survival. , 2002, Trends in immunology.

[7]  D. Martin,et al.  Transcriptional enhancers--on/off gene regulation as an adaptation to silencing in higher eukaryotic nuclei. , 2001, Trends in genetics : TIG.

[8]  D. F. Barber,et al.  Inhibition of natural killer cell activation signals by killer cell immunoglobulin‐like receptors (CD158) , 2001, Immunological reviews.

[9]  B. Hazes,et al.  Specificity and function of activating Ly‐49 receptors , 2001, Immunological reviews.

[10]  Michael J. Wilson,et al.  The genomic context of natural killer receptor extended gene families , 2001, Immunological reviews.

[11]  R. Biassoni,et al.  Human natural killer cell receptors and co‐receptors , 2001, Immunological reviews.

[12]  M. Llano,et al.  Human cytomegalovirus and natural killer‐mediated surveillance of HLA class I expression: a paradigm of host–pathogen adaptation , 2001, Immunological reviews.

[13]  S. S. Chuang,et al.  A Prominent Role for Activator Protein-1 in the Transcription of the Human 2B4 (CD244) Gene in NK Cells1 , 2001, The Journal of Immunology.

[14]  B. Wilhelm,et al.  Comparative analysis of the promoter regions and transcriptional start sites of mouse Ly49 genes , 2001, Immunogenetics.

[15]  P. Parham,et al.  The Repertoire of Killer Cell Ig-Like Receptor and CD94:NKG2A Receptors in T Cells: Clones Sharing Identical αβ TCR Rearrangement Express Highly Diverse Killer Cell Ig-Like Receptor Patterns1 , 2001, The Journal of Immunology.

[16]  P. Parham,et al.  Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1 , 2001, The Journal of Immunology.

[17]  William H. Carr,et al.  Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism1 , 2001, The Journal of Immunology.

[18]  M. Bonneville,et al.  Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements1 , 2001, The Journal of Immunology.

[19]  Peter Parham,et al.  Short KIR Haplotypes in Pygmy Chimpanzee (Bonobo) Resemble the Conserved Framework of Diverse Human KIR Haplotypes , 2001, The Journal of experimental medicine.

[20]  H. Lehrach,et al.  The NKG2 natural killer cell receptor family: comparative analysis of promoter sequences , 2000, Genes and Immunity.

[21]  T. Mak,et al.  Deficiency in the Transcription Factor Interferon Regulatory Factor (Irf)-2 Leads to Severely Compromised Development of Natural Killer and T Helper Type 1 Cells , 2000, The Journal of experimental medicine.

[22]  J. Yen,et al.  Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis1 , 2000, The Journal of Immunology.

[23]  C. Roth,et al.  Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. , 2000, Immunity.

[24]  D. G. Muir,et al.  Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. , 2000, Immunity.

[25]  S. Beck,et al.  Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Witt,et al.  Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. , 1999, Transplantation.

[27]  C. Lutz,et al.  Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity. , 1999, Cancer research.

[28]  H Clevers,et al.  Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. , 1999, Immunity.

[29]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[30]  D. Speiser,et al.  CD28‐negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients , 1999, European journal of immunology.

[31]  J. Altman,et al.  Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b , 1998, The Journal of experimental medicine.

[32]  N Muthusamy,et al.  The Ets-1 transcription factor is required for the development of natural killer cells in mice. , 1998, Immunity.

[33]  Michele Cilli,et al.  p49, a putative HLA class I‐specific inhibitory NK receptor belonging to the immunoglobulin superfamily , 1998, European journal of immunology.

[34]  H. Lehrach,et al.  Structure of the human CD94 C-type lectin gene , 1998, Immunogenetics.

[35]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[36]  J. Dorfman,et al.  Acquisition of Ly49 Receptor Expression by Developing Natural Killer Cells , 1998, The Journal of experimental medicine.

[37]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[38]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[39]  M. Kubin,et al.  A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. , 1997, Journal of immunology.

[40]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[41]  Eric O Long,et al.  A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. , 1997, Journal of immunology.

[42]  S. Smale,et al.  Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. , 1997, Biochimica et biophysica acta.

[43]  Y. Zhang,et al.  Non-killer cell-specific transcription factors silence the perforin promoter. , 1997, Journal of immunology.

[44]  P. Stern,et al.  Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. , 1997, Immunology today.

[45]  A. Fauci,et al.  Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Roy,et al.  Core promoters and transcriptional control. , 1996, Trends in genetics : TIG.

[47]  O. Mandelboim,et al.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules , 1996, The Journal of experimental medicine.

[48]  J. O’Shea,et al.  Differential basal protein tyrosine phosphorylation in natural killer (NK) and T cells: a biochemical correlate of lymphoid functional activity. , 1996, Cellular immunology.

[49]  P. Parham,et al.  Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype , 1996, The Journal of experimental medicine.

[50]  P. Parham,et al.  NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules , 1994, The Journal of experimental medicine.

[51]  E. Ciccone,et al.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition , 1990, The Journal of experimental medicine.

[52]  K. Struhl,et al.  A wide variety of DNA sequences can functionally replace a yeast TATA element for transcriptional activation. , 1990, Genes & development.

[53]  G. Pantaleo,et al.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function , 1990, The Journal of experimental medicine.

[54]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[55]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[56]  W. O'Fallon,et al.  Formation of the Killer Ig-Like Receptor Repertoire on CD4 CD28 T Cells , 2002 .

[57]  P. Parham,et al.  Genetic control of human NK cell repertoire , 2001 .

[58]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[59]  F. Takei,et al.  Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression. , 2000, European journal of immunology.

[60]  T Lagrange,et al.  New core promoter element in RNA polymerase II-dependent transcription: sequence-specific DNA binding by transcription factor IIB. , 1998, Genes & development.

[61]  T. Heinemeyer,et al.  Databases on transcriptional regulation : TRANSFAC , TRRD and COMPEL , 1997 .

[62]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.